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Nordic walking (NW) was established in the 1930s, when Finnish cross-country skiers used their poles for summer training, with the acronym NW coined in 1997. Evidence 
suggests a beneficial effect for people with Parkinson’s 
disease (PwP) from NW in improving posture, gait and 
stability. In a questionnaire aimed at regular Nordic 
walkers, (Stevinson and Brown, 2019) 411 people 
responded that NW was a form of  exercise that was 
beneficial, well tolerated and sustainable over many 
years. It is enjoyed by people with a wide range of long-
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term health conditions and advancing age, who were 
reported to be healthier and happier than their age-
matched peers (Stevinson and Brown, 2019). Spending 
time outdoors was the largest reported benefit, with 
fitness, mental wellbeing and weight management 
scoring highly. The same study recorded perceived 
barriers, although at lower rates than identified benefits; 
time, cost, weather, health and transport to the venue 
were cited. NW has been endorsed by Parkinson’s UK 
(www. parkinsons.org.uk) and British Nordic Walking 
(www.britishnordicwalking.org.uk), but there is little 
research to guide implementation of NW in the NHS 
or social care settings. Additionally, there are barriers to 
NW for PwP, such as the cost of poles, the availability 
of  specialist training, time, the stigma of  using two 
poles and it being predominantly a female activity 
(Stevinson and Brown, 2019). In 2014, a British woman 
with Parkinson’s disease started the first UK NW 
group for PwP. In 2019, Parkinson’s UK and British 
Nordic walking established an early pilot phase site in 
Nottinghamshire and trained the first NHS PD nurse 
in the country as an accredited NW instructor (SM). 
Aims
The aims of  the present study were to explore the 
barriers and facilitators to PwP taking up NW, to 
discover any indication of  effectiveness and inform 
implementation in the NHS. The research questions are: 
	● Does NW influence mobility in PwP?
	● Does NW improve wellbeing? 
	● What are the barriers to NW?
Methods
This study was carried out in line with the UK 
government COVID-19 guidelines, both clinical and 
non-clinical. It is a mixed-methods feasibility study 
using quantitative data from physical outcome measures 
and qualitative questionnaires. The data collection 
period was 10 weeks, with 8 weeks of NW intervention. 
A literature review was completed to inform the pre- 
and post-intervention study. For this paper, the methods 
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ABSTRACT
Background: Nordic walking (NW) has shown promising outcomes for 
people with Parkinson’s disease (PwP). Aims: To explore the feasibility of 
the implementation of NW programmes for PwP in the NHS.  Methods: A 
literature review and feasibility study were conducted. PwP joined an 
8-week NW programme. Attendance and measures of mobility (Timed Up 
and Go (TUG), 10-metre walk test (10MWT) and quality of life (QoL) (PD 
non-motor questionnaire) were recorded pre- and post-intervention. 
Barriers, facilitators and cost were recorded.  Findings: Eight studies 
indicated that NW is superior to walking and flexibility/relaxation exercise, 
with improvements in postural stability and gait. Nine of 10 participants 
completed the intervention with improvements in mobility (0.16 seconds 
faster (TUG), 1.27 seconds faster (10MWT) and QoL (better sleep, pain 
management, constipation, mood, exercising outside) after the 
intervention. Cost was recorded as £6.50 per participant per session, 
with no adverse events.  Conclusions: NW programmes can be safely 
delivered in the NHS, in partnership with British Nordic walking. 
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for both stages are presented before the results. Ethical 
approval was given by the University of Nottingham. 
Literature review 
The scoping literature review of international research 
was completed with the following search terms: ‘NW’, 
‘PD’, ‘exercise’ and ‘mobility’. The following databases 
were searched from 2008 to 2020: PubMed, CINAHL 
and the Cochrane Library. Randomised controlled 
trials, cohort studies and systematic reviews were 
included. Nine papers were reviewed; one was excluded 
because the intervention was not delivered using the 
correct International Nordic walking Federation 
(INWA) technique, leaving eight studies in the 
final review.
Participant recruitment
No participants were recruited until all necessary/
ethical approvals were in place.
The participants were recruited via two sources: local 
PD UK social groups and neuro-physiotherapists. The 
lead researcher (SM) presented the study at PD branch 
meetings, where leaflets were distributed, and anyone 
who wanted to take part contacted the research team 
with their details. The researcher made contact with 
potential participants and sent them the participant 
information sheet. The participants met SM to complete 
the consent and provided their details, including name, 
age, time since diagnosis, gender, ethnicity, address and 
email address, to help in defining the sample and to 
remain in contact with the researcher. Demographic 
details were collected, but patients’ identifiable data 
was removed. Each participant was assigned a letter 
(A–I). Consent was given for the use of  photographs 
in this article. 
Intervention
Participants were invited to eight (1 hour) sessions 
of NW at the University of  Nottingham campus, led 
by SM, a PD nurse specialist and trained PD NW 
instructor. No individual advice was given about 
medications, but general advice regarding Parkinson’s 
symptoms, management, exercise and lifestyle were 
offered. Each class included a series of  warm-up 
exercises, instruction on the use of the NW poles and 
a step-by-step guide to the ten steps of  NW, as per 
the International NW Association guidelines (inwa-
nordicwalking.com). Walking with the group included 
warm-up exercises; specific drills to improve technique, 
arm swing, good posture and stride length; a guided 
Nordic walk; and cool down stretches. Classes were 
tailored to the group’s ability and endurance levels. 
Individual support and advice was given regarding NW 
technique and the safety of the group was maintained, 
including weekly emails to remind participants to 
bring a hat, sun cream, water and their medication. 
Walking shoes were advised for most surfaces, but 
the intervention also included experimentation with 
various terrains, including short grass, longer grass, 
tarmac and sand. Videos of the participants were used 
to aid teaching. 
The cost of  delivering the NW programme was 
calculated and included the instructor’s time and 
travel, equipment, telephone calls, leaflets and training. 
There were additional costs due to the COVID-19 
pandemic, including hand sanitising gels, clinical 
wipes and the purchase of  additional poles so that 
each participant had an individual set of poles for the 
duration of the project. The originally planned larger 
group was spilt into two smaller groups to comply with 
government guidelines regarding group size and social 
distancing. Time taken by the instructor to deliver two 
sessions increased, as a morning and afternoon group 
was delivered. 
Outcome measures
Participants completed the following standardised 
quantitative measurements at baseline and at the end 
of the eight sessions; this took 15–20 minutes to collect. 
Changes in mobility were assessed with the 10-Metre 
Walk Test (10MWT), which determines the time taken 
to walk 10 metres without a walking aid and the number 
of  steps taken to walk 10 metres (Watson, 2002), 
and the Timed Up and Go (TUG) test (Podsiadlo et 
al, 1991), in which participants were asked to get out 
of  their chair, walk 3 metres, turn, return 3 metres 
to the chair and sit down. Wellbeing was partially 
assessed using the validated and well-used Non-Motor 
Symptoms Questionnaire (NMSQ) (Chaudhuri et al, 
2007) and through the field notes. This questionnaire 
consists of 30 questions, each answered yes or no. The 
questionnaire contains items relating to mood, falls, 
sleep, leg pain, constipation, weight, and so on. Field 
notes and informal comments were collected by the NW 
instructor during the classes and written up immediately 
after the session. They were not digitally recorded. The 
main conversation topics were barriers and facilitators 
to the NW programme, but also concerned how 
participants had coped with the lockdown. 
Analysis and data storage
The studies from the literature review were analysed 
using a narrative approach. The participant sample was 
described as a group using their personal characteristics, 
but names and addresses were removed. Data from the 
outcome measures were stored on an Excel database 
and analysed using descriptive statistics (mean, median, 
ranges and standard deviation). Qualitative data from 
the field notes, non-motor questionnaire and a simple 
barriers/benefits questionnaire, devised from the 
literature, were transcribed and analysed using thematic 
analysis (Braun and Clarke, 2006). The data was 
checked by a second researcher; this is later presented as 
a word cloud and then woven into the assessment data 
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to answer the research questions. Case studies from the 
NW instructor’s field notes are presented.
Results
The literature search found eight randomised controlled 
trials. A comparative table of  results can be seen in 
Appendix 1. It shows trends across the studies, with 
most using the same outcome measures: TUG, 10MWT 
and NMSQ score. These are standardised, published 
and validated tools, which the authors chose to replicate 
in the present study. 
In a Dutch study (van Eijkeren et al, 2008) where 
subjects were tested at baseline and after 6 weeks of 
bi-weekly NW intervention, and followed up with at 
5 months, there were significant improvements in the 
10MWT and TUG tests (Podsiadlo and Richardson, 
1991) and in the quality of  life questionnaire (PDQ-
39) (Jenkinson et al, 1998). Positive results persisted 
up to the 5 month follow-up assessment. In one paper 
(Reuter et al, 2011), 90 participants were randomised 
to three different forms of exercise: flexibility exercises 
and relaxation, NW, or ‘just walking’. Data suggested 
that NW was superior to the alternatives in improving 
stride length, gait and balance. Blake (2015) studied 
10 participants who had PD and completed a NW 
programme over 8–10 weeks. Results indicated that 
NW improved walking ability, with signs of a positive 
impact on mental health (Blake, 2015). An Italian study 
(Cugusi, 2015) had similar findings, with improvements 
from baseline on the TUG test, NMSQ (Chaudhuri, 
2007) scores and a 6-metre walk test. 
The results of these studies provided an evidence base 
to the Nottingham feasibility study, with standardised 
outcome measures from larger clinical trials within the 
context of PD. The research team identified that the use 
of these standardised measures would facilitate further 
future expansion of the study within a different setting.
 
Feasibility study
Ten people with PD were recruited and consented 
to participate in the feasibility intervention study. 
Although eager to take part, one participant was 
excluded during pre-study health screening because 
of a disclosure of serious cardiac problems. The final 
group comprised of  nine PwP (three women and six Figure 2. Field notes’ key themes 
Figure 1. The Nordic walking group
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men) (Figure 1). The mean age was 62 years, with a 
mean duration since diagnosis of  5 years. Quantitative 
outcome measure data are found in Table 1, with 
the field notes’ key themes (high-frequency words) 
presented in a word cloud (Figure 2). These data 
highlight the participants’ collective positivity: their 
determination, resilience, perseverance and mutual 
support. Some participants were also very honest 
about their struggles with mental health, low mood, 
anxieties, fear of  falling and fear of  the COVID-19 
virus. Outcome measures, non-motor benefits and the 
key themes from the field notes have been merged in 
the text.
Theme 1. Benefits of Nordic walking 
All nine participants attended and participated in 
the NW programme. Some 15 out of  16 planned 
NW sessions took place, with one cancelled due to 
a heatwave. Sessions still took place when there was 
rain forecast.
Participants commented that the benefits far 
outweighed the barriers. They enjoyed meeting at the 
university’s sports field, and found that the venue was 
conducive to NW. The programme was conducted 
during a holiday period, and few people were around 
as a result. Participants reported that they felt safe 
from a COVID-19 risk perspective. Parking was free 
and the venue was easy to find. Coincidentally, three 
participants were university alumni and were pleased to 
be back at their former place of education. This could 
be noted as potential recruitment bias, as they were 
keen to participate in the research. 
‘The Nordic poles look sporty and I felt energised 
and stimulated after the classes.’
(Participant H)
Participants commented that they did not feel silly 
exercising as a group and enquired about buying 
their own poles, which can be taken as an indication 
that they wanted to continue to Nordic walk after 
the research intervention. Several participants stated 
that they planned to join a local NW group after the 
study finished. They specifically said that the poles 
helped them to maintain a better walking position, 
upright posture and a longer stride. One participant 
stated that two poles increased her confidence, while 
another reported that it took a lot of  concentration 
to coordinate the technique; however, viewing a video 
of  herself  and her technique enabled her to see her 
improvement. People enjoyed exercising regularly 
in a group and reported the intervention to be a 
motivating factor. 
‘I’m not a great lover of exercise, but this is fun, 
especially in a group.’ 
(Participant H)
Most of  the participants reported enjoyment and 
satisfaction at the end of  each class and said they 
preferred exercising in the fresh air, rather than 
partaking in online exercise classes.
‘It gives us a legitimate reason to meet together 
and to exercise when everybody else is stuck inside 
on Zoom!’ 
(Participant I)
Case study 1 
During a NW session on a hot and humid afternoon, 
one participant (Figure 3), who could sometimes run 
when he could not walk, had a significant freezing 
episode. He took remedial action and was supported 
by other group members, highlighting the benefits 















A:     51 6.31 5.6    (0.71) 12 12 6.16 5.44 (0.72)
B:     74 7.5 6.4    (1.06) 13 12 (1) 8.19 7.94 (0.25)
C:     60 6.22 6.25  (-0.03) 14 11 (3) 6.62 6.97 (-0.35)
D:     64 6.07 6.53  (-0.46) 11 12 (-1) 6.44 6.91 (-0.47)
E:     62 19 12.09 (6.91) 20 19 (1) 15.32 22.38 (-7.06)
F:     58 7.22 6.9    (0.32) 15 14 (1) 9.21 7.32 (1.89)
G:    51 6.34 5.65  (0.69) 13 11 (2) 7.87 5.62 (2.25)
H:    60 6.18 5.03  (1.15) 13 12 6.47 5.44 (1.03)
I:     77 8.69 7.57  (1.12) 17 15 (2) 11.81 8.59 (3.22)
Mean: 62 years 127 secs 1 step 0.16 secs
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of peer group support. When asked whether he had 
enough ‘fuel in the tank’ (dopamine), he believed that 
he could run once his medication had taken effect. At 
this point, SM ran with him to catch up with the group 
and they reached the terminus first. This highlighted 
the requirement for a second instructor/INWA-trained 
physiotherapist/walk leader for larger groups with 
mixed abilities. 
Theme 2: Nordic walking during a 
COVID-19 lockdown
The first UK lockdown occurred between 23 March and 
1 July 2020, overlapping with this study. Field note data 
indicated that most participants continued to regularly 
exercise to overcome gaps in their usual routines. 
However, they preferred exercising outside rather than 
engaging in online classes. Figure 3 displays reported 
activities, with the most popular being walking outside. 
Several participants reported struggles with the early 
restrictions and social isolation. As a whole, the group 
reported an enjoyment of  the NW classes because it 
gave them a reason to exercise outside. Notably, one 
female participant reported: 
It’s good discipline to go every week; even if I feel 
tired, I always feel better afterwards.’ 
(Participant H)
Participant A took her Nordic poles on holiday and 
practiced walking on the beach, occasionally with 
bare feet. People reported that walking on short grass 
provided improved pole traction and propulsion. 
Overall, participants reported a sense of  fun and 
pleasure when combining listening to music with 
NW:
‘The music was very motivating and uplifting, 
and it was a sunny day. It helped rhythm, 
coordination and pace.’
(Participant A)
This finding suggests that the use of  music can 
facilitate improved rhythm and pace in NW, while 
enhancing enjoyment. 
The chart below is a summary of  the exercise that 
the participants were engaging in during lockdown. 
Notably, one man (participant C) had tried a few 
taster sessions of  NW, but was still eligible to join 
the research project. 
Theme 3: barriers to Nordic walking
Figure 4 illustrates NW barriers and reflects 
participants’ field note data. However, data suggests 
that these barriers diminished over time and 
were hardly mentioned in later field notes. Some 
participants reported a sense of  self-consciousness, 
frailty and impairment because they used two ‘sticks’, 
with a reluctance to exercise alone or in a public area 
without a group. A perception that the technique 
would be difficult, due to suboptimal coordination 
and balance, was also reported. Wet grass and light 
rain hindered attendance, whereas others enjoyed 
the opportunity to exercise outside in the summer 
months with others in a COVID-safe, supportive, 
green space. Comorbidities and emerging memory 
problems were a barrier to one male participant 
perfecting the technique, but participation was 
facilitated and he enjoyed the sessions. Three people 
were afraid of  falling, but reported that they felt the 
Nordic technique had helped them with balance, 
posture and gait. 
Financial implications
The cost of  this intervention was calculated by adding 
the cost of  the instructor’s time (one day per week; 
band 7 Parkinson’s nurse specialist) and a proportion 
of  the training cost (British Nordic Walking), the 
proportion of  the cost of  equipment (10 sets of  poles 
at £50 per pair) and the cost of  the venue, which was 
then divided by the number of  participation (n=9).
Using these calculations, it is estimated that, if  
the NHS were to provide this intervention, it would 
cost £12–£15 per person per session. Research 
participants were not charged for participation; if  
they subsequently attend an established NW group, 
they could pay £6.50 per hour (this excluded pole 
purchase of  between £50–£140). Figure 3. A participant and park runner
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Outcomes: the effect of Nordic walking 
on mobility and general wellbeing
All participants completed the outcome measures at 
the start and end of  the programme and contributed 
to the field notes. Seven participants improved on the 
10MWT and were faster walkers after the intervention. 
Later analysis suggested that 10MWT might not be 
useful as a short-term walking speed measure, but it 
might produce useful long-term data, perhaps at 6 
or 9 months. Most participants improved their times 
on the TUG test over a distance of  3 metres. Data 
for all participants is shown in Table 1; these include 
mean scores for the 10MWT, number of  steps and 
TUG. The numbers in brackets reflect the difference 
between the baseline and final scores after 8 weeks of 
NW instruction.
The greatest improvement overall was from the 
oldest participant (I), at 77 years of  age. She was 
generally very slow in class, but made the most 
significant improvement in all outcome measures: 3.22 
seconds faster during the TUG test, which equals an 
27.3% improvement. In the field notes, this participant 
reported improvements in lower back pain from 
the regular NW sessions. There was a small overall 
improvement in the 10MWT, due to significant gains 
by participant E. He did very well walking in a straight 
line, but struggled with TUG due to his self-declared 
cognitive decline and difficulty following instruction. 
The youngest male (participant G), at 51 years of age, 
also showed improvement in the TUG test, being 28% 
faster after 8 weeks of  intervention. One participant 
(male, participant F) reported stumbles and falls at 
home. He enjoyed the class and improved in all three 
domains, with a TUG improvement of  21%. He 
reported that the programme motivated him to exercise 
on his own, and that he would continue to use his poles 
after the intervention. One participant (participant 
E) struggled to follow the instructions, had low blood 
pressure and was prone to fainting. His wife joined the 
classes and supported him for his safety, highlighting 
the benefits of family involvement.
Discussion
The key findings of  this study were that PwP were 
happy to take part this type of  study and especially 
enjoyed the NW programme, even in poor weather. All 
participants reported a sense of  fun, with a positive 
impact on their health and mobility; all were eager to 
carry on with NW. Outcome measure data reinforces 
participant qualitative field note data. Finally, most 
mobility and quality of  life scores improved over 
time. NW is a relatively low-cost outdoor activity on 
a pay-as-you-go basis and has the potential to attract 
low-income or hard-to-reach communities through 
the absence of  membership fees. There is potential 
for partnership with Parkinson’s UK and British 
Nordic Walking to facilitate widespread access to NW 
opportunities. 
The results from this study are in line with the 
results from studies by Blake (2015), Cugusi (2017) and 
Monteiro (2017), which also showed improvements in 
walking speed, stride length and non-motor symptoms. 
The results add to the literature, alongside the findings 
of Stevinson and Brown (2019), regarding the benefits 














































































































Figure 4. Barriers to Nordic walking
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Strengths and limitations
The main limitation from this study was that the 
outcome measures and field notes were collected by the 
NW instructor, who also provided the intervention; this 
holds the potential for positive bias reporting. However, 
this risk was mitigated by the use of quantitative and 
standardised outcome measures, which were collected 
by the lead researcher and a research assistant with the 
use of  published guidelines. Future research should 
use a blinded researcher. Another limitation was the 
small sample size, which means that outcome measure 
generalisability could be compromised.
A further limitation was that balance and posture 
outcome measures were not recorded. Future studies 
should consider such measures, as most participants 
reported improvements in both domains. Due to the 
nature of  study funding, repeat measures were taken 
within a short period after the intervention. Future 
studies should consider a longer term follow-up at 6 
and 9 months.
A significant study strength was the recruitment 
pathway, which was via routine PD groups and NHS 
services. Provided that the instructor is INWA-trained, 
this improves the result’s generalisability to other NHS 
settings and appropriate patient groups. Importantly, 
findings also highlight the necessity for a second 
trained instructor (NW instructor, walk leader or a 
NW-trained physiotherapist). The purpose of  this 
additional presence would be to help assess exercise 
suitability and safety, data collection and group safety.
It is possible that the reported benefits could have 
occurred as the result of  other activities, including 
advice given within the NW classes. However, the 
authors consider that the results are useful for people 
considering setting up a NW group or researchers, 
adding to other small studies, thus building a 
foundation to a large randomised controlled trial of 
NW provided by the NHS. 
Another significant strength was that a patient and 
public involvement representative joined the project. 
He attended most of  the NW classes and was an 
active member of  the project team, offering first-hand 
experience and critique. He understood the bigger 
picture and the whole person approach, connecting 
time spent outdoors and structured exercise to benefit 
mind and body.
                 
Future implementation and research
Using the results of  this study, the research team plan 
to implement an 8-week rolling programme of  NW at 
the University of Nottingham, working collaboratively 
with an NHS PD nurse specialist, a physiotherapist 
and a second NW instructor/walk leader. Participants 
will be recruited through the local PD branches, 
physiotherapy colleagues, social prescribing and GPs. 
Regarding issues with medical and cognitive fitness in 
learning new techniques and exercises, before engaging 
in classes, all participants will be assessed using 
bespoke measures, including postural blood pressure, 
pulse, oxygen levels, medical/cognitive history, 
medication history and the Physical Activity Readiness 
Questionnaire (PAR-Q) (British Columbia Ministry 
of  Health and Multidisciplinary Board on Exercise, 
1992). Participants will also benefit from one-to-one 
technique coaching sessions. In the event of  inclement 
weather, the NW class could be available indoors. 
Signposting and referral to existing NW programmes 
(not necessarily PD-specific) at the end of  the session 
will be made, to assist ongoing engagement. Separate 
SportSupport
Normal: x-n (μ, ∂)
Figure 5. ‘Support’ to ‘sport’ 
KEY POINTS
 ■ Nordic walking is well tolerated by people with Parkinson’s disease. It 
is an enjoyable outdoor sport that is relatively affordable, accessible 
and safe in a post-COVID context
 ■ Nordic walking has been shown to be beneficial to those with 
Parkinson’s, due to improvements in gait, stride length and speed 
of walking 
 ■ There are promising non-motor benefits that might include 
improvements in sleep, pain (in particular, lower back pain), 
constipation and mood
 ■ There may be cost benefits to the NHS regarding falls reduction and 
improved mental health.
CPD REFLECTIVE QUESTIONS
 ■ Do people with Parkinson’s disease have access to Nordic walking in 
your area? If not, what might you do in your practice to facilitate this?
 ■ Given the benefits demonstrated in this research, is Nordic walking 
something you might suggest to your patients?
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classes for different ability groups will be offered. The 
same outcome measures will be taken following the 
intervention, with the addition of  balance, using the 
Berg Balance Scale (Berg et al, 1989), and posture, 
using the Tragus measurement (Haywood et al, 2004). 
A 6- and 9-month assessment to check for longer-
term effects and engagement will be completed. 
Once the programme is embedded, we will consider 
a clinical and economic evaluation in a randomised 
controlled trial.
Another consideration is whether NW would be 
effective at reducing the impact of  Long COVID, due 
to the physical and mental health benefits of  exercising 
in a small group outdoors. This would certainly be a 
novel and timely piece of  research, as the COVID-19 
pandemic has had a seismic impact upon PwP and 
their families. Helmich and Bloem (2020) describe 
the hidden sorrows and emerging opportunities to 
deliver a different model of  Parkinson’s service. 
Technological innovation and outdoor exercise appear 
to be promising interventions. Figure 5 illustrates the 
rationale behind the therapeutic benefit of  outdoor 
exercise, especially to those with long-term health 
conditions, with ‘sport’ and ‘support’ theory becoming 
inextricably linked (Carver-Richardson et al, 2019). 
In light of  the COVID-19 restrictions, which may 
again be imposed, data suggests NW to be a safe 
outdoor sport that can be performed in small, socially 
distanced groups. 
Conclusion
This feasibility study provides evidence that NW can be 
delivered with success by the NHS at relatively low cost 
per participant. The objective of the recommendations 
made is to assist clinicians, researchers and 
policymakers in the formation and delivery of  PD 
services. However, once NW has been implemented as 
part of  a management programme, it will be essential 
to complete a more comprehensive and larger trial to 
evaluate clinical and cost effectiveness. bjnn
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